The U.S. artificial corneal implants market size was estimated at USD 39.1 Million in 2024 and is projected to reach USD 69.8 million by 2033, growing at a CAGR of 6.65% from 2025 to 2033. The market is driven by an increasing prevalence of corneal disorders such as corneal blindness and a shortage of cornea donors, which is leading patients and surgeons to seek synthetic alternatives.
The market is driven by increasing incidences of Keratoconus, Stevens-Johnson syndrome, and corneal scarring, which remain leading causes of vision impairment. The increasing prevalence of these disorders among the aging U.S. population has further increased the need for effective treatment solutions. According to the National Council on Aging, in 2022, the U.S. had 57.8 million adults aged 65 and older, comprising 31.9 million women and 25.9 million men.
To address this demand, key market participants invest heavily in R&D, securing regulatory approvals, and collaborating with clinical and academic institutions to introduce innovative implant solutions. Strategic initiatives, including partnerships, geographic expansion, and integration of advanced biomaterials, enhance their competitive positioning and expand market reach. In January 2025, Pantheon Vision collaborated with Eyedeal Medical to advance production and commercialization of its bioengineered corneal implant. Pantheon completed three FDA review meetings for Premarket approval (PMA) guidance. The partnership aimed to address limitations of donor corneas by offering bioengineered corneal implants and restoring vision in patients with corneal blindness.
This product will be delivered within 2 business days.
The market is driven by increasing incidences of Keratoconus, Stevens-Johnson syndrome, and corneal scarring, which remain leading causes of vision impairment. The increasing prevalence of these disorders among the aging U.S. population has further increased the need for effective treatment solutions. According to the National Council on Aging, in 2022, the U.S. had 57.8 million adults aged 65 and older, comprising 31.9 million women and 25.9 million men.
To address this demand, key market participants invest heavily in R&D, securing regulatory approvals, and collaborating with clinical and academic institutions to introduce innovative implant solutions. Strategic initiatives, including partnerships, geographic expansion, and integration of advanced biomaterials, enhance their competitive positioning and expand market reach. In January 2025, Pantheon Vision collaborated with Eyedeal Medical to advance production and commercialization of its bioengineered corneal implant. Pantheon completed three FDA review meetings for Premarket approval (PMA) guidance. The partnership aimed to address limitations of donor corneas by offering bioengineered corneal implants and restoring vision in patients with corneal blindness.
U.S. Artificial Corneal Implants Market Report Segmentation
This report forecasts revenue growth at country level as well as provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. artificial corneal implants market report on the basis of transplant type, indication, implant type, and end-use:Transplant Type Outlook (Revenue, USD Million, 2021-2033)
- Hard Keratprosthesis
- Soft Keratoprosthesis
Indication Outlook (Revenue, USD Million, 2021-2033)
- Stevens-Johnson Syndrome (SJS)
- Ocular Cicatricial Pemphigoid (OCP)
- Ocular burns
- Keratoconus
- Corneal Stromal Dystrophies
- Others
Implant Type Outlook (Revenue, USD Million, 2021-2033)
- Synthetic
- Biosynthetic
End-use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Ophthalmic Centers
- Ambulatory Surgical Centers
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Artificial Corneal Implants Market Variables, Trends & Scope
Chapter 4. U.S. Artificial Corneal Implants Market: Transplant Type Estimates & Trend Analysis
Chapter 5. U.S. Artificial Corneal Implants Market: Indication Estimates & Trend Analysis
Chapter 6. U.S. Artificial Corneal Implants Market: Implant Type Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players profiled in this U.S. Artificial Corneal Implants market report include:- orneaGen
- JL Ophthalmic S.A.
- lcon Inc.
- eraMed, Inc.
- CI
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | September 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 39.1 Million |
| Forecasted Market Value ( USD | $ 69.8 Million |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | United States |
| No. of Companies Mentioned | 6 |
